4期

[2005-5-5] A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis [2005-5-5] A novel SHP-1/Grb2–dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine [2005-5-5] A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation [2005-5-5] Allergen exposure–induced differences in CD34+ cell phenotype: relationship to eosinophilopoietic responses in different compartments [2005-5-5] And a final message from antithrombin [2005-5-5] Antiangiogenic antithrombin down-regulates the expression of the proangiogenic heparan sulfate proteoglycan, perlecan, in endothelial cells [2005-5-5] Antibody-induced intracellular signaling works in combination with radiation to eradicate lymphoma in radioimmunotherapy [2005-5-5] Anti-CD40L: biology and therapy in ITP [2005-5-5] BUBR1 deficiency results in abnormal megakaryopoiesis [2005-5-5] Cell adhesion: a partner for many [2005-5-5] Chemokine receptor–8 (CCR8) mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion [2005-5-5] Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation [2005-5-5] Coagulation inflammation, and apoptosis: different roles for protein S and the protein S–C4b binding protein complex [2005-5-5] CXCR4 engagement is required for HIV-1–induced L-selectin shedding [2005-5-5] Cyclophosphamide metabolism is affected by azole antifungals [2005-5-5] Deletion of the -globin gene cluster as a cause of acquired -thalassemia in myelodysplastic syndrome [2005-5-5] Dimerize and die [2005-5-5] Direct killing of Epstein-Barr virus (EBV)–infected B cells by CD4 T cells directed against the EBV lytic protein BHRF1 [2005-5-5] Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses [2005-5-5] Dual roles of the C-terminal Src kinase (Csk) during developmental vascularization [2005-5-5] Dynamic regulation of Src-family kinases by CD45 in B cells [2005-5-5] Early prediction of response in patients with relapsed or refractory Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ALL) treated w [2005-5-5] Endothelial progenitor cells in infantile hemangioma [2005-5-5] ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cell lymphoma oncoprotein [2005-5-5] Eµ-BRD2 transgenic mice develop B-cell lymphoma and leukemia [2005-5-5] Fc-RIIIa and Fc-RIIa polymorphisms do not predict response to rituximab in B-cell chronic lymphocytic leukemia [2005-5-5] Functional endothelial cells derived from rhesus monkey embryonic stem cells [2005-5-5] Fungal infection in hemato-oncologic patients: better to prevent than to treat? [2005-5-5] Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9 [2005-5-5] HFE a putative hepatocyte iron sensor? [2005-5-5] High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation [2005-5-5] Identification and characterization of EBP a novel EEN binding protein that inhibits Ras signaling and is recruited into the nucleus by the MLL-EEN f [2005-5-5] Identification of a 4-base deletion in the gene in inherited intrinsic factor deficiency [2005-5-5] Identification of the molecular requirements for an RAR-mediated cell cycle arrest during granulocytic differentiation [2005-5-5] In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation [2005-5-5] Ineffective hematopoiesis linked with a mitochondrial tRNA mutation (G3242A) in a patient with myelodysplastic syndrome [2005-5-5] Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants [2005-5-5] Localization of iron metabolism–related mRNAs in rat liver indicate that HFE is expressed predominantly in hepatocytes [2005-5-5] LPAM (47 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease [2005-5-5] Molecular characterization of ADAMTS13 gene mutations in Japanese patients with Upshaw-Schulman syndrome [2005-5-5] Novel concatameric heparin-binding peptides reverse heparin and low-molecular-weight heparin anticoagulant activities in patient plasma in vitro and i [2005-5-5] Pharmacologically regulated Fas-mediated death of adoptively transferred T cells in a nonhuman primate model [2005-5-5] Platelet collagen receptors play molecular ping-pong [2005-5-5] Prior chemotherapy and allograft CD34+ dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in patients with [2005-5-5] Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL [2005-5-5] Regulation of MHC class II expression in human T-cell malignancies [2005-5-5] Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PET [2005-5-5] Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells [2005-5-5] Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia [2005-5-5] Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients [2005-5-5] Signaling by ephrinB1 and Eph kinases in platelets promotes Rap1 activation platelet adhesion, and aggregation via effector pathways that do not requ [2005-5-5] Specific inhibition of HIV-1 coreceptor activity by synthetic peptides corresponding to the predicted extracellular loops of CCR5 [2005-5-5] Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP [2005-5-5] Swinging for the fences: persistent and efficient liver-directed gene therapy for hemophilia A [2005-5-5] The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leu [2005-5-5] The myelodysplastic syndromes: heterogeneneity on many levels [2005-5-5] Thymosin 4 induces the synthesis of plasminogen activator inhibitor 1 in cultured endothelial cells and increases its extracellular expression [2005-5-5] Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype [2005-5-5] Transfer of allogeneic CD62L– memory T cells without graft-versus-host disease